Latest news
25 items- SECSEC Form 15-12B filed by Itamar Medical Ltd.15-12B - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form EFFECT filed by Itamar Medical Ltd.EFFECT - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form EFFECT filed by Itamar Medical Ltd.EFFECT - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form POS AM filed by Itamar Medical Ltd.POS AM - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form POS AM filed by Itamar Medical Ltd.POS AM - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form S-8 POS filed by Itamar Medical Ltd.S-8 POS - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form S-8 POS filed by Itamar Medical Ltd.S-8 POS - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 25-NSE filed by Itamar Medical Ltd.25-NSE - Itamar Medical Ltd. (0001613170) (Subject)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- PRItamar Medical Reports Third Quarter 2021 Financial Results- Revenues Increased 23% Year-over-Year to $13.6 Million - - U.S. WatchPAT™ Revenues Increased 27% Year-over-Year to $11.3 Million - CAESAREA, Israel, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today reported unaudited financial results for the third quarter of 2021. "Third quarter results represent the strong traction our WatchPAT™ platform technology has gained entering the second half of 2021. Growth in the U.S. continues to outpace our overall growth on top of expanding adoption in the markets we serve thr
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- 13D/GSEC Form SC 13G/A filed by Itamar Medical Ltd. (Amendment)SC 13G/A - Itamar Medical Ltd. (0001613170) (Subject)
- ANALYSTItamar Medical downgraded by SVB Leerink with a new price targetSVB Leerink downgraded Itamar Medical from Outperform to Market Perform and set a new price target of $31.00 from $30.00 previously
- ANALYSTItamar Medical downgraded by Ladenburg Thalmann with a new price targetLadenburg Thalmann downgraded Itamar Medical from Buy to Neutral and set a new price target of $33.85
- ANALYSTItamar Medical downgraded by HC Wainwright & Co. with a new price targetHC Wainwright & Co. downgraded Itamar Medical from Buy to Neutral and set a new price target of $31.00 from $36.00 previously
- ANALYSTItamar Medical downgraded by Cowen & Co. with a new price targetCowen & Co. downgraded Itamar Medical from Outperform to Market Perform and set a new price target of $31.00 from $30.00 previously
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K/A filed by Itamar Medical Ltd. (Amendment)6-K/A - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
- SECSEC Form 6-K filed by Itamar Medical Ltd.6-K - Itamar Medical Ltd. (0001613170) (Filer)
ITMR FAQ
7 questionsWhat does Itamar Medical Ltd. do?
Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist...Where does ITMR stock trade?
Itamar Medical Ltd. (ITMR) is listed on NASDAQ.What sector and industry is ITMR in?
Itamar Medical Ltd. operates in the Health Care sector, Medical/Dental Instruments industry.When did Itamar Medical Ltd. go public?
Itamar Medical Ltd. (ITMR) completed its IPO in n/a.What are analysts saying about ITMR?
Itamar Medical Ltd. has had 4 recent analyst actions on file. The most recent action was from SVB Leerink: Market Perform with a $3100.00 price target on 2021-09-20. Recent price targets range from $3100.00 to $3385.00.What companies are similar to ITMR?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare ITMR side-by-side with any of them on Quantisnow.How can I track ITMR on Quantisnow?
Quantisnow aggregates Itamar Medical Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ITMR to receive live email and push alerts on every new disclosure.